PubMed:21921061 / 740-1002 JSONTXT

{"project":"Glycan-Motif","denotations":[{"id":"T21","span":{"begin":19,"end":22},"obj":"https://glytoucan.org/Structures/Glycans/G46613JI"},{"id":"T22","span":{"begin":19,"end":22},"obj":"https://glytoucan.org/Structures/Glycans/G48558GR"},{"id":"T23","span":{"begin":23,"end":27},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T24","span":{"begin":23,"end":27},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T21","span":{"begin":19,"end":22},"obj":"Glycan_Motif"},{"id":"T23","span":{"begin":23,"end":27},"obj":"Glycan_Motif"}],"attributes":[{"id":"A21","pred":"image","subj":"T21","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR"},{"id":"A22","pred":"image","subj":"T21","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI"},{"id":"A23","pred":"image","subj":"T23","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC"},{"id":"A24","pred":"image","subj":"T23","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T21","span":{"begin":19,"end":22},"obj":"https://glytoucan.org/Structures/Glycans/G46613JI"},{"id":"T22","span":{"begin":19,"end":22},"obj":"https://glytoucan.org/Structures/Glycans/G48558GR"},{"id":"T23","span":{"begin":23,"end":27},"obj":"https://glytoucan.org/Structures/Glycans/G46677TE"},{"id":"T24","span":{"begin":23,"end":27},"obj":"https://glytoucan.org/Structures/Glycans/G69277LC"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T12","span":{"begin":19,"end":22},"obj":"http://www.glycoepitope.jp/epitopes/EP0050"},{"id":"T13","span":{"begin":23,"end":27},"obj":"http://www.glycoepitope.jp/epitopes/EP0056"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T17","span":{"begin":108,"end":123},"obj":"FMAID:82742"},{"id":"_T18","span":{"begin":108,"end":123},"obj":"FMAID:196731"},{"id":"_T19","span":{"begin":124,"end":134},"obj":"FMAID:167180"},{"id":"_T20","span":{"begin":164,"end":180},"obj":"FMAID:196731"},{"id":"_T21","span":{"begin":164,"end":180},"obj":"FMAID:82742"},{"id":"_T22","span":{"begin":237,"end":247},"obj":"FMAID:167180"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"uniprot-human","denotations":[{"id":"T3","span":{"begin":258,"end":261},"obj":"http://www.uniprot.org/uniprot/P56915"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T1","span":{"begin":148,"end":155},"obj":"http://purl.bioontology.org/ontology/STY/T096"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GO-BP","denotations":[{"id":"T3","span":{"begin":65,"end":69},"obj":"http://purl.obolibrary.org/obo/GO_0004617"},{"id":"T4","span":{"begin":93,"end":102},"obj":"http://purl.obolibrary.org/obo/GO_0032502"},{"id":"T5","span":{"begin":227,"end":236},"obj":"http://purl.obolibrary.org/obo/GO_0032502"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GO-MF","denotations":[{"id":"T3","span":{"begin":124,"end":134},"obj":"http://purl.obolibrary.org/obo/GO_0003823"},{"id":"T4","span":{"begin":237,"end":247},"obj":"http://purl.obolibrary.org/obo/GO_0003823"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GO-CC","denotations":[{"id":"T3","span":{"begin":258,"end":261},"obj":"http://purl.obolibrary.org/obo/GO_0032593"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T6","span":{"begin":0,"end":262},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":262},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":262},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlycoBiology-Epitope","denotations":[{"id":"PD-GlycoEpitope-B_T6","span":{"begin":19,"end":22},"obj":"http://www.glycoepitope.jp/epitopes/EP0050"},{"id":"PD-GlycoEpitope-B_T14","span":{"begin":23,"end":27},"obj":"http://www.glycoepitope.jp/epitopes/EP0056"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"mondo_disease","denotations":[{"id":"T5","span":{"begin":75,"end":78},"obj":"Disease"},{"id":"T6","span":{"begin":214,"end":217},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T11","span":{"begin":19,"end":22},"obj":"Glycan"},{"id":"T12","span":{"begin":23,"end":27},"obj":"Glycan"}],"attributes":[{"id":"A11","pred":"glycosmos_id","subj":"T11","obj":"https://glycosmos.org/glycans/show/G48558GR"},{"id":"A25","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR"},{"id":"A12","pred":"glycosmos_id","subj":"T12","obj":"https://glycosmos.org/glycans/show/G46677TE"},{"id":"A26","pred":"image","subj":"T12","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlyCosmos-GlycoEpitope","denotations":[{"id":"T11","span":{"begin":19,"end":22},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T12","span":{"begin":23,"end":27},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A11","pred":"glycoepitope_id","subj":"T11","obj":"http://www.glycoepitope.jp/epitopes/EP0050"},{"id":"A12","pred":"glycoepitope_id","subj":"T12","obj":"http://www.glycoepitope.jp/epitopes/EP0056"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T5","span":{"begin":75,"end":78},"obj":"Disease"},{"id":"T6","span":{"begin":214,"end":217},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlyCosmos15-NCBITAXON","denotations":[{"id":"T1","span":{"begin":59,"end":64},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T6","span":{"begin":0,"end":262},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":262},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":262},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T6","span":{"begin":0,"end":262},"obj":"Sentence"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T11","span":{"begin":19,"end":22},"obj":"Glycan"},{"id":"T12","span":{"begin":23,"end":27},"obj":"Glycan"}],"attributes":[{"id":"A11","pred":"glycosmos_id","subj":"T11","obj":"https://glycosmos.org/glycans/show/G48558GR"},{"id":"A25","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR"},{"id":"A12","pred":"glycosmos_id","subj":"T12","obj":"https://glycosmos.org/glycans/show/G46677TE"},{"id":"A26","pred":"image","subj":"T12","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"GlyCosmos15-GlycoEpitope","denotations":[{"id":"T11","span":{"begin":19,"end":22},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T12","span":{"begin":23,"end":27},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A11","pred":"glycoepitope_id","subj":"T11","obj":"http://www.glycoepitope.jp/epitopes/EP0050"},{"id":"A12","pred":"glycoepitope_id","subj":"T12","obj":"http://www.glycoepitope.jp/epitopes/EP0056"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}

{"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":59,"end":64},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"}],"text":"The hybrid dimeric GM1-GD1a was specifically recognized by human sera from GBS patients that developed anti-oligosaccharide antibodies specific for grouped complex oligosaccharides, confirming the information that GBS patients developed antibodies against a GSC."}